Parallel Trade US Lawmakers Allow Imported Prescriptions Drugs Please Note: Reports are sold based on the user licenses indicated. The reports will be accessible in Flash format via an online reading room on the publisher website, allowing viewing... |
Pharmacy Automation Technologies and Global Markets Highlights:
The total worldwide market for pharmacy automation will be worth $2.2 billion by the end of 2010. The market is displaying a recovery from purchasing holds for equipment experienced by... |
OTC Obesity - Norway Sales of OTC obesity products reached NOK10 million in 2009 following the introduction of the first clinically-approved product in this category.
Euromonitor International's OTC Obesity Products in Norway report offers a... |
Portugal Pharmaceuticals and Healthcare Report Q2 2011 Portugal's pharmaceutical market was worth EUR3.59bn (US$4.77bn) in 2010, and drug market expenditure is likely to remain at a similar level in 2011. Several factors have contributed to the slowdown... |
eHealthInsight Series: Reaching Doctors and Patients Through New Digital Media Introduction
Existing sales and marketing models are considered unsustainable. Pharma has been slow to adapt and take advantage of the marketing opportunities offered by the internet. Meanwhile customers are increasingly using... |
OTC market in Poland 2010 Switch strategies and development forecasts for 2010-2012 The report is a comprehensive analysis of the OTC market in Poland, with a closer look at drugs, dietary supplements and dermocosmetics. The historical data and development forecasts for the... |
Telemedicine This report analyzes the worldwide markets for Telemedicine in US$ Millions. The report analyzes the market for telemedicine by the following segments: Technology (Hardware/Equipment, Software, & Telecommunications & Network), and... |
Frost & Sullivan Speaks Candidly with U.S. Pharmacists This study encompasses feedback provided by a healthcare pharmacist research panel consisting of 10-15 pre-selected participants and were conducted via online moderated discussion boards over a three-day period. Series of... |
Portugal Pharmaceuticals and Healthcare Report Q3 2011 BMI View: Portugal is typical of many Western European markets. It is mature, with little scope for growth and is subject to downward pressures on pricing and the demands of... |
Pharmaceutical Distribution in the US Current and Future Perspectives In recent years, the US government and interested parties have made increasing efforts to protect the national supply chain for medicines distribution. Since it represents the means for medicines to... |
Prospects for Legalizing Drug (Re-)Importation to the United States President Barack Obama said during his election campaign he would 'allow Americans to buy their medicines from other developed countries if the drugs are safe and prices are lower outside... |
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution Issues, initiatives and insights for supply chain integrity Introduction
Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation... |
Distribution on the Pharmaceutical Market in Poland 2011. Development forecasts for 2011-2013 Distribution on the pharmaceutical market in Poland 2011, development forecasts for 2011 to 2013 was created in order to satisfy increasing client requests for in depth reporting, comprehensive data and... |
Pharmaceutical Pricing Global perspectives Pharmaceutical Pricing - Global Perspectives is a strategic report, that analyses all aspects of pharmaceutical pricing and reimbursement strategies through extensive use of case studies.
The pricing of new pharmaceutical... |
Future of European Pharmaceutical Distribution, The The impact of DTP on manufacturers and wholesalers Reducing the number of wholesalers helps to reduce internal costs for manufacturers, and by dealing only with a few wholesalers may create more manageable business relationships
The European pharmaceutical distribution system... |
Personalizing Disease Management Through Technology Solutions Part II - Vendor Landscape Introduction
Disease management is not a new concept in the healthcare industry and despite the heterogeneity that characterizes this field, such programs are becoming an important part of the healthcare sector.... |